SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD INCREASE OOP COSTS AND PREMIUMS FOR SENIORS — DO NOTHING TO LOWER RX PRICES
Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It… Read More

Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It… Read More
Lawmakers Blast Big Pharma Executives During Two-Day Hearing on… Read More
Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes… Read More
Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More… Read More
Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering… Read More
Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Beat Wall… Read More
Little Surprise Big Pharma Bailout That Would Hike Medicare Premiums Was A… Read More
Brand Name Drug Companies Continue Streak of Beating Wall Street Expectations… Read More
Brand Name Drug Companies See Soaring Profits After Hiking Prices Today… Read More
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giant… Read More
Brand Name Big Pharma Giants Surpass Expectations After Hiking Prices New… Read More
Reception of Misguided Reboot Focuses on Premium Increases, Cost to Taxpayers,… Read More